Alendronate increases bone mineral density in long-term renal transplant recipients.
Koc
M
M
University School of Medicine, Division of Nephrology, Istanbul, Turkey.
Tuglular
S
S
Arikan
H
H
Ozener
C
C
Akoglu
E
E
D015502:Absorptiometry, Photon; D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D002117:Calcitriol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000601:surgery; D012086:Reoperation; D013997:Time Factors; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D002117:Calcitriol; D019386:Alendronate